Fresenius Kabi Deutschland GmbH

Fresenius Kabi is a leading healthcare company dedicated to the development and provision of life-saving medicines and technologies. As part of the Fresenius Group, which has been in existence for over 100 years, Fresenius Kabi meets the needs of critically and chronically ill patients through innovative products and services.

• Biopharma: Fresenius Kabi offers advanced biosimilars for the treatment of autoimmune diseases and cancer.
• Clinical Nutrition: The company offers a wide range of enteral and parenteral nutrition products.
• MedTech: This includes infusion pumps, cell and gene therapy devices, and essential consumables for blood banks and medical facilities for delivery.
• I.V. Generics: The infusion solutions and generics make a significant contribution to saving millions of lives, especially in emergency medicine, surgery, oncology and intensive care medicine.

Fresenius Kabi is guided by the Fresenius Principles, which focus on excellent quality, innovation and collaboration. The company is committed to serving patients beyond expectations and respectfully looks to the future needs of society.

Fresenius Kabi is committed to creating sustainable value for its stakeholders and is a member of the Pharmaceutical Supply Chain Initiative (PSCI) to improve ethical, social and environmental standards in the supply chain.

Fresenius Kabi strives with its Vision 2026 to be recognized as a leading provider of therapies worldwide and to continuously improve the care of critically and chronically ill patients. With over 41,000 employees in more than 100 countries and more than 450 million patients annually, the company places a strong focus on global healthcare and adheres to a mission based on Excellence, Collaboration and Innovation.

• 1 - https://www.fresenius-kabi.com/us
• 2 - https://www.fresenius-kabi.com/us/company
• 3 - https://www.fresenius-kabi.com/company/about-us
• 4 - https://www.fresenius.com/fresenius-kabi
• 5 - https://en.wikipedia.org/wiki/Fresenius_(company)